Eisai Co Ltd 4523
News
Biogen's stock stumbles as Alzheimer's drug is rejected by European regulators
Eli Lilly's Alzheimer's drug wins FDA approval
Eli Lilly's Alzheimer's drug gets backing from FDA advisers
Eli Lilly's Alzheimer's drug to face safety, dosing scrutiny from FDA advisers
Biogen's stock climbs as first-quarter profit tops estimates, Alzheimer's drug uptake improves
Merck and Eisai combination endometrial cancer treatment fails to meet goals in clinical trial
Merck, Eisai: Keytruda/Lenvima Combo Fails in 1st-Line Endometrial Cancer Study
Biogen and Eisai release new Alzheimer's drug data that may support wider uptake
Merck, Eisai: Keytruda/Lenvima Combo Fails in Two Non-Small Cell Lung Cancer Studies
Merck and Eisai say two lung-cancer trials failed to meet their main goals